Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
NMTC	NEUROONE MEDICAL TECHNOLOGIES CORP	United States	$29.72M	27,515,921	15.62%	8.04%	Net Buying	Net Selling
GENE	GENETIC TECHNOLOGIES LTD	Australia	$526.30k	115,417,246	0.06%	0.00%
POCI	PRECISION OPTICS CORPORATION INC	United States	$38.96M	6,068,518	9.37%	90.63%
SNTI	SENTI BIOSCIENCES INC	United States	$17.48M	45,755,021	23.95%	52.51%
MYNZ	MAINZ BIOMED NV	Germany	$14.39M	21,165,482	0.69%	0.00%
ICCT	ICORECONNECT INC	United States	$11.47M	10,240,398	3.17%	0.00%
BNTC	BENITEC BIOPHARMA INC	Australia	$88.90M	9,367,485	13.57%	10.33%
GNLX	GENELUX CORP	United States	$98.54M	26,996,740	22.29%	5.19%	Net Selling	Net Selling
AORT	ARTIVION INC	United States	$979.09M	41,734,442	77.29%	22.71%	Net Selling	Net Selling
BIAF	BIOAFFINITY TECHNOLOGIES INC	United States	$26.35M	11,657,537	2.01%	36.86%	Net Buying	Net Buying
MRAI	MARPAI INC	United States	$21.65M	10,308,038	2.16%	79.56%	Net Buying	Net Buying
LGVN	LONGEVERON INC	United States	$8.13M	6,348,624	0.33%	99.67%	Net Buying	Net Buying
CYTK	CYTOKINETICS INC	United States	$6.24B	104,853,918	88.53%	11.47%	Net Selling	Net Selling
GYRE	GYRE THERAPEUTICS INC	United States	$1.22B	85,510,116	0.50%	99.50%	Net Buying	Net Buying
CELU	CELULARITY INC	United States	$58.13M	19,378,164	0.57%	99.43%	Net Buying	Net Selling
THMO	THERMOGENESIS HOLDINGS INC	United States	$4.67M	7,952,780	0.22%	99.78%	Net Buying	Net Buying
VIRX	VIRACTA THERAPEUTICS INC	United States	$31.69M	39,272,434	3.50%	96.50%	Net Buying	Net Selling
CYBN	CYBIN INC	Canada	$143.93M	411,216,132	76.66%	0.00%
ASXC	ASENSUS SURGICAL INC	United States	$70.81M	272,331,675	8.80%	60.16%	Net Selling	Net Selling
OGI	ORGANIGRAM HOLDINGS INC	Canada	$190.83M	94,468,558	11.81%	0.00%
KYTX	KYVERNA THERAPEUTICS INC	United States	$664.84M	43,115,244	57.91%	42.09%	Net Buying
STXS	STEREOTAXIS INC	United States	$173.55M	82,643,243	27.35%	72.65%	Net Buying
STSS	SHARPS TECHNOLOGY INC	United States	$3.45M	15,670,898	7.40%	23.64%	Net Buying	Net Buying
XLO	XILIO THERAPEUTICS INC	United States	$42.08M	36,912,373	29.79%	68.66%	Net Buying	Net Buying
AIMD	AINOS INC	United States	$6.54M	6,284,300	0.63%	99.37%	Net Buying
MURA	MURAL ONCOLOGY PLC	Ireland	$63.63M	16,923,878	71.45%	2.66%
ATEC	ALPHATEC HOLDINGS INC	United States	$1.55B	139,883,919	21.64%	78.36%	Net Selling	Net Selling
AHG	AKSO HEALTH GROUP	China	$16.06M	68,598,050	0.40%	0.00%
MTNB	MATINAS BIOPHARMA HOLDINGS INC	United States	$42.64M	250,816,164	10.15%	11.91%
VANI	VIVANI MEDICAL INC	United States	$109.68M	54,978,465	4.37%	95.63%	Net Buying
BCDA	BIOCARDIA INC	United States	$10.70M	27,304,116	0.97%	99.03%	Net Buying	Net Buying
RSLS	RESHAPE LIFESCIENCES INC	United States	$4.13M	23,457,090	1.14%	93.06%	Net Buying
TPST	TEMPEST THERAPEUTICS INC	United States	$70.65M	22,217,265	3.46%	96.54%
CRDL	CARDIOL THERAPEUTICS INC	Canada	$139.09M	64,097,536	10.23%	0.00%
CPIX	CUMBERLAND PHARMACEUTICALS INC	United States	$21.43M	14,191,229	15.24%	58.39%	Net Buying	Net Selling
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	United States	$5.53M	2,249,290	2.45%	97.55%	Net Buying
GOVX	GEOVAX LABS INC	United States	$3.92M	2,308,309	0.09%	99.91%	Net Buying	Net Buying
CRGX	CARGO THERAPEUTICS INC	United States	$804.06M	39,375,963	72.14%	27.86%	Net Buying
ENSC	ENSYSCE BIOSCIENCES INC	United States	$4.73M	7,585,172	3.95%	56.03%
ANL	ADLAI NORTYE LTD	United States	$488.44M	110,700,805	0.05%	0.00%
ILMN	ILLUMINA INC	United States	$17.69B	159,300,000	89.03%	1.99%	Net Selling	Net Buying
RARE	ULTRAGENYX PHARMACEUTICAL INC	United States	$3.48B	83,133,341	83.24%	16.76%	Net Selling	Net Selling
CKPT	CHECKPOINT THERAPEUTICS INC	United States	$69.28M	36,850,279	14.58%	8.97%	Net Selling	Net Selling
CERE	CEREVEL THERAPEUTICS HOLDINGS INC	United States	$7.67B	182,194,722	26.70%	73.30%	Net Buying	Net Buying
VERU	VERU INC	United States	$193.23M	146,383,920	32.65%	28.45%	Net Selling	Net Selling
LXEO	LEXEO THERAPEUTICS INC	United States	$456.29M	32,945,341	70.17%	20.74%	Net Buying	Net Buying
SCPX	SCORPIUS HOLDINGS INC	United States	$3.71M	36,031,964	6.16%	17.31%
ESLA	ESTRELLA IMMUNOPHARMA INC	United States	$36.92M	36,376,293	0.37%	80.86%	Net Selling
DARE	DARE BIOSCIENCE INC	United States	$49.03M	101,092,900	6.75%	25.30%
TCBP	TC BIOPHARM (HOLDINGS) PLC	United Kingdom	$5.59M	98,902,641	0.02%	7.33%
CMMB	CHEMOMAB THERAPEUTICS LTD	Israel	$11.96M	284,379,960	0.94%	5.95%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	Hong Kong	$67.80M	13,012,866	0.01%	0.00%
VCNX	VACCINEX INC	United States	$8.78M	1,584,300	4.32%	95.68%	Net Buying	Net Buying
PROK	PROKIDNEY CORP	United States	$939.54M	231,698,039	11.59%	36.21%	Net Selling	Net Buying
CTLT	CATALENT INC	United States	$10.02B	180,979,849	77.50%	22.50%	Net Buying	Net Selling
XTLB	XTL BIOPHARMACEUTICALS LTD	United States	$14.67M	544,906,149	0.05%	20.78%
PHIO	PHIO PHARMACEUTICALS CORP	United States	$3.61M	4,591,700	0.12%	99.88%	Net Buying	Net Buying
NVCT	NUVECTIS PHARMA INC	United States	$112.89M	18,356,060	8.51%	49.28%	Net Buying	Net Buying
CRIS	CURIS INC	United States	$69.55M	5,894,085	3.52%	96.48%
BSGM	BIOSIG TECHNOLOGIES INC	United States	$18.48M	11,198,174	3.66%	96.34%	Net Buying
PLSE	PULSE BIOSCIENCES INC	United States	$431.31M	55,225,333	8.61%	78.41%	Net Buying
ANRO	ALTO NEUROSCIENCE INC	United States	$335.24M	26,883,990	59.01%	24.97%	Net Buying	Net Buying
CARA	CARA THERAPEUTICS INC	United States	$41.01M	54,675,954	43.18%	53.39%	Net Selling	Net Selling
LFCR	LIFECORE BIOMEDICAL INC	United States	$179.31M	30,546,936	49.55%	50.45%
CGON	CG ONCOLOGY INC	United States	$2.00B	66,640,150	56.08%	16.44%	Net Buying
ASMB	ASSEMBLY BIOSCIENCES INC	United States	$80.11M	5,513,308	2.24%	97.76%	Net Buying	Net Selling
PRTG	PORTAGE BIOTECH INC	Canada	$5.06M	19,778,000	10.84%	0.00%
KALV	KALVISTA PHARMACEUTICALS INC	United States	$502.88M	42,188,296	54.17%	45.83%	Net Buying	Net Selling
SANA	SANA BIOTECHNOLOGY INC	United States	$1.93B	221,502,908	51.17%	48.83%	Net Buying	Net Selling
NEXI	NEXIMMUNE INC	United States	$4.57M	1,371,051	1.97%	98.03%	Net Selling
AVGR	AVINGER INC	United States	$6.09M	1,702,226	1.21%	98.79%	Net Selling
CHRO	CHROMOCELL THERAPEUTICS CORP	United States	$10.09M	5,766,704	4.37%	48.62%	Net Buying	Net Buying
PHVS	PHARVARIS NV	Netherlands	$1.10B	53,816,707	78.83%	0.00%
AVBP	ARRIVENT BIOPHARMA INC	United States	$673.22M	33,493,750	65.24%	31.26%	Net Buying
PAVM	PAVMED INC	United States	$16.88M	9,431,721	5.43%	94.57%
NMRA	NEUMORA THERAPEUTICS INC	United States	$1.54B	159,523,997	24.67%	75.33%	Net Buying
REVB	REVELATION BIOSCIENCES INC	United States	$3.30M	1,632,935	0.08%	99.92%	Net Selling
CLRB	CELLECTAR BIOSCIENCES INC	United States	$118.30M	35,848,924	25.47%	11.43%
IMNN	IMUNON INC	United States	$13.16M	9,400,889	3.57%	92.01%
MIRA	MIRA PHARMACEUTICALS INC	United States	$9.68M	14,780,885	3.77%	30.26%	Net Buying
EDSA	EDESA BIOTECH INC	Canada	$14.63M	3,215,968	1.26%	98.74%	Net Buying	Net Buying
OPK	OPKO HEALTH INC	United States	$920.03M	696,991,677	16.30%	83.70%	Net Buying	Net Buying
RVP	RETRACTABLE TECHNOLOGIES INC	United States	$30.54M	29,937,159	6.56%	93.44%	Net Buying	Net Buying
KOD	KODIAK SCIENCES INC	United States	$173.37M	52,534,947	68.53%	31.47%	Net Selling
NAMS	NEWAMSTERDAM PHARMA CO NV	Netherlands	$1.81B	89,976,538	63.66%	36.34%	Net Selling	Net Selling
SLRX	SALARIUS PHARMACEUTICALS INC	United States	$2.36M	4,776,433	1.63%	98.37%
APLM	APOLLOMICS INC	United States	$29.71M	89,495,790	10.33%	0.00%
KALA	KALA BIO INC	United States	$18.45M	2,816,454	1.24%	98.76%	Net Selling
CNTX	CONTEXT THERAPEUTICS INC	United States	$150.00M	74,998,312	5.25%	1.54%
MBIO	MUSTANG BIO INC	United States	$3.90M	12,514,890	5.70%	20.39%
APDN	APPLIED DNA SCIENCES INC	United States	$2.47M	984,728	17.77%	82.23%
JAGX	JAGUAR HEALTH INC	United States	$76.53M	295,474,346	1.97%	3.25%
VRPX	VIRPAX PHARMACEUTICALS INC	United States	$914.73k	1,171,233	0.02%	99.98%
ICCC	IMMUCELL CORP	United States	$37.58M	7,811,874	12.94%	24.12%	Net Buying
MRSN	MERSANA THERAPEUTICS INC	United States	$334.05M	122,361,236	43.83%	56.17%	Net Selling
WORX	SCWORX CORP	United States	$2.58M	1,211,035	1.11%	98.89%
AKBA	AKEBIA THERAPEUTICS INC	United States	$241.04M	209,596,378	27.21%	8.82%	Net Selling	Net Selling
BACK	IMAC HOLDINGS INC	United States	$3.88M	1,148,321	5.66%	94.34%
RNAZ	TRANSCODE THERAPEUTICS INC	United States	$7.62M	6,622,053	5.46%	52.39%	Net Buying
RHE	REGIONAL HEALTH PROPERTIES INC	United States	$5.02M	1,839,028	0.18%	99.82%	Net Buying

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	679	-0.70%	+1.84%	+3.96%	-19.69%	8.47x	6.01x	+18.62%	+3.83%	-27.52%	+77.73%	Strong Buy
Diagnostics & Research	64	-0.44%	+1.56%	+12.99%	+11.25%	38.96x	4.47x	-13.18%	+6.48%	+11.49%	+5.02%	Buy
Drug Manufacturers - General	18	-0.03%	+1.66%	+7.51%	+18.11%	31.85x	6.42x	+33.60%	+8.10%	+14.22%	+11.01%	Buy
Drug Manufacturers - Specialty & Generic	87	-0.75%	+1.10%	+5.60%	-1.99%	-1.01x	2.20x	+12.36%	+3.36%	+6.05%	+32.29%	Strong Buy
Healthcare Plans	12	+0.52%	+1.22%	+4.66%	+4.46%	25.53x	3.07x	+15.18%	+4.74%	+11.78%	+11.78%	Buy
Health Information Services	61	+0.25%	+2.04%	-0.03%	-19.66%	9.15x	3.33x	+6.71%	+2.23%	+5.33%	+26.88%	Buy
Medical Care Facilities	51	-0.09%	+0.01%	+4.96%	+11.10%	39.23x	4.59x	-92.23%	+6.58%	+13.66%	+15.22%	Buy
Medical Devices	150	-0.35%	+1.37%	+2.08%	-13.46%	30.60x	4.00x	+7.35%	+5.26%	+8.26%	+19.86%	Buy
Medical Distribution	10	+0.87%	+0.34%	+1.16%	+26.37%	26.84x	107.17x	-11.87%	+3.44%	+19.58%	+10.98%	Buy
Medical Instruments & Supplies	56	+0.16%	+1.85%	+6.62%	-5.76%	59.83x	3.64x	+11.25%	+7.73%	+10.05%	+18.23%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 46 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -42.43% over the past year, underperforming other healthcare stocks by -37 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 33.84% from Cross Country Healthcare's current stock price of $14.57.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the second best healthcare stock with a Zen Score of 67, which is 43 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 14.93% over the past year, overperforming other healthcare stocks by 21 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 44.77% from Corcept Therapeutics's current stock price of $28.09.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) is the third best healthcare stock with a Zen Score of 65, which is 41 points higher than the healthcare sector average of 24. It passed 20 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 12.82% over the past year, overperforming other healthcare stocks by 19 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 104.84% from Kamada's current stock price of $5.37.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Sanofi (NASDAQ:SNY)

Sanofi (NASDAQ:SNY) has an annual dividend yield of 8.1%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Sanofi's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 82.1% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.93%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.88%, which is 6 percentage points higher than the healthcare sector average of 2.05%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.28% in the last day, and up 1.47% over the last week. Heart Test Laboratories was the among the top losers in the healthcare sector, dropping -38.37% yesterday.

Heart Test Laboratories shares are trading lower after the company's 1-for-100 reverse stock split began trading on a split-adjusted basis.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -44.03% in the past year. It has underperformed other stocks in the healthcare sector by -38 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -23.81% in the past year. It has underperformed other stocks in the healthcare sector by -18 percentage points.

3. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Cross Country Healthcare has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Cross Country Healthcare's stock has dropped -42.43% in the past year. It has underperformed other stocks in the healthcare sector by -37 percentage points.

Are healthcare stocks a good buy now?

50.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 32.6% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.